Recombinant gene effectors and compositions and methods of use thereof
JP2025510781APending Publication Date: 2025-04-15EPICRISPR BIOTECHNOLOGIES INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- JP2024556421
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-03-13
- Filing Date
- 2023-03-23
- Publication Date
- 2025-04-15
Smart Images

Figure 2025510781000001_ABST
Abstract
The present disclosure provides one or more recombinant gene effectors, as well as systems, compositions and methods of use thereof, wherein the one or more recombinant gene effectors of the present disclosure can be used to regulate a target gene in a cell (e.g., an endogenous target gene in a cell).The one or more recombinant gene effectors of the present disclosure can be operably linked to a heterologous endonuclease, such as a CRISPR / Cas protein.
Need to check novelty before this filing date? Find Prior Art